Dayer, Pierre

 
Title Year Hits Downloads
Admission to intensive care: A qualitative study of triage and its determinants 2018 41 1
Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist 2015 204 3
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements 2015 203 5
P-glycoprotein: a clue to vitamin K antagonist stabilization 2015 266 0
Volunteers trained in palliative care at the hospital: An original and dynamic resource 2015 311 0
Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques 2015 249 4
Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping Cocktail 2014 245 1
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis 2014 99 0
Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spots 2014 359 123
Doctors' Decisions When Faced With Contradictory Patient Advance Directives and Health Care Proxy Opinion: A Randomized Vignette-Based Study 2014 236 0
Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in Fibromyalgia 2014 282 1
Impact of Advance Directives and a Health Care Proxy on Doctors' Decisions: A Randomized Trial 2014 263 2
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial 2013 211 874
Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study 2013 279 1
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain 2013 372 408
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers 2013 221 213
Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital 2013 295 259
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study 2013 270 188
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis 2013 282 116
Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model 2013 222 0
Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs 2013 270 330
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment 2013 270 0
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model 2013 183 0
Transcriptional regulation of CYP2C19 and its role in altered enzyme activity 2012 192 2
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers 2012 220 712
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot 2012 263 0
Quel programme informatique de détection des interactions médicamenteuses néfastes ? 2012 451 483
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry 2012 322 349
Fracture atypique du fémur sous bisphosphonates, un effet indésirable à ne pas manquer 2012 325 0
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview 2012 233 172
Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism 2012 297 183
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro 2012 194 0
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients 2011 246 0
Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite 2011 267 270
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination 2011 174 0
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia 2011 386 6
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone 2009 252 2
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital 2009 250 1
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein 2009 274 1
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction 2009 359 5
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study 2009 245 2
Pharmacogenetics of analgesics: toward the individualization of prescription 2008 262 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers 2008 321 0
New approaches to the pharmacotherapy of neuropathic pain 2008 217 0
La prescription « off-label » 2008 190 0
Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoprotein 2008 261 3
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients 2008 248 1
Patients' representations of antidepressants: a clue to nonadherence? 2007 102 1
Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique 2007 75 0
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study 2007 278 1
Prise en charge médicamenteuse des troubles psychologiques et comportementaux lies à la démence 2006 156 0
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis 2006 150 2
Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors 2006 100 63
Entre sel et gènes ou pharmacogénomique des antihypertenseurs 2006 67 0
Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor 2005 212 2
Le traitement de l'hypertension artérielle : un défi pour le praticien 2005 82 0
Sélection d'un médicament dans une classe thérapeutique donnée : l'exemple des «inhibiteurs de l'HMG-CoA réductase» 2005 90 0
Polymorphisme génétique et interactions médicamenteuses: leur importance dans le traitement de la douleur 2005 106 65
Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasone 2005 84 0
QT interval prolongation in patients on methadone with concomitant drugs 2004 94 0
Codeine intoxication associated with ultrarapid CYP2D6 metabolism 2004 106 0
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia 2003 118 146
Clinical pharmacology and rationale of analgesic combinations 2003 78 0
Advances with analgesics and NSAIDs for the treatment of spinal disorders 2002 101 32
Simultaneous stereoselective analysis of tramadol and its main phase I metabolites by on-line capillary zone electrophoresis-electrospray ionization mass spectrometry 2000 267 1
Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan 1999 75 27
Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex 1998 104 0
Use of the label "litigation neurosis" in patients with somatoform pain disorder 1998 88 54
Pharmacologie du tramadol 1997 320 1
Stereoselective interaction between piroxicam and acenocoumarol 1996 269 7
Influence of rifampin on fleroxacin pharmacokinetics 1993 247 0
In vitro forecasting of drugs that may interfere with codeine bioactivation 1992 61 21
Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI) 1988 77 57
15589 5201